Clinical measurement of myocardial infarct size.  Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.
A modified method for the measurement of total creatine phosphokinase release from venous blood samples taken four-hourly after myocardial infarction has been used in 43 patients admitted to a Coronary Care Unit.  The fractional decay rate (Kd) of enzyme activity has been measured by a standardized method in each patient, and accuracy of the calculation of total enzyme release has been improved by allowance for individual variations in decay rate, and discarding of data from which decay rates cannot be measured within confidence limits of less than plus or minus 15 per cent.  Total enzyme release was greater in cases of transmural infarction than in patients with subendocardial infarction, and showed a good positive correlation with clinical indices of the extent of myocardial damage.  As noted by previous workers, this method allows for the measurement of the rate as well as the extent of enzyme release, and so should prove useful in the clinical evaluation of therapeutic agents which might accelerate or retard the rate of myocardial necrosis in patients with acute myocardial infarction.
D001800:Blood Specimen Collection / Q000379:methods; D002404:Catheterization / Q000379:methods; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase / Q000097:blood*; D005069:Evaluation Studies as Topic; D006801:Humans; D008722:Methods; D009203:Myocardial Infarction / Q000175:diagnosis / Q000201:enzymology*; D009206:Myocardium / Q000201:enzymology; D011379:Prognosis; D013053:Spectrophotometry; D014680:Veins
D003402:Creatine Kinase